Renaissance Technologies
LABD icon

Renaissance Technologies’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Renaissance Technologies’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+47,500
New +$639K ﹤0.01% 2716
2020
Q4 		– Sell
-787
Closed -$470K – 3570
2020
Q3 		$470K Buy
+787
New +$508K ﹤0.01% 2830

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Renaissance Technologies's LABD Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 47,500 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #2716 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in LABD as recently as Q3 2020.

Renaissance Technologies first reported a position in LABD in Q3 2020 and has held it in 2 quarters since. The position peaked at $470K in Q3 2020. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Renaissance Technologies held 47,500 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $366K as of Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new Renaissance Technologies position in Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2716 holding.
  • Renaissance Technologies first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2020 and has held it in 2 quarters since.
  • Renaissance Technologies's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $470K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.